Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Defence is the Best Attack: Immuno-Oncology Breakthroughs
Barcelona, Spain : 9 - 11 May 2023
Scientific Programme
To download and print the programme, use the links below.
Listed times are in Central European Summer Time (CEST)
REGISTRATION & WELCOME LUNCH
CONFERENCE WELCOME
Session 1
Chair: Joan Seoane
OPENING KEYNOTE LECTURE
Alberto Mantovani Humanitas University, Italy
"Innate immunity, inflammation and cancer from bench to bedside"
Q&A: 13:40-13:55
Jennifer Guerriero Brigham and Women’s Hospital / Harvard Medical School, USA
“Targeting novel populations of macrophages for anti-cancer therapy”
Q&A: 14:15 - 14:25
Krijn Dijkstra Antoni van Leeuwenhoek - Netherlands Cancer Institute, Netherlands
Proffered Paper 1: "Patient-derived co-cultures of TRACERx lung cancer organoids and autologous T-cells reveal heterogeneity in immune evasion between cancer subclones"
Q&A: 14:35 - 14:40
EXHIBITOR INTRODUCTIONS
60-second intro pitches by each company
COFFEE BREAK & EXHIBITION
Session 2
Chair: Ignacio Melero
Joan Seoane Vall d'Hebron Institute of Oncology (VHIO), Spain
"Impact of the tumor microenvironment on immunotherapy"
Q&A: 15:40 - 15:50
Sonia Guedan Hospital Clínic de Barcelona, Spain
"CAR-T cells for the treatment of solid tumors"
Q&A: 16:10 - 16:20
Poster Spotlights
3 top abstracts presented as 3-minute flash talks
Alena Gros Vall d'Hebron Institute of Oncology (VHIO), Spain
"Towards tailored antitumor T-cell therapies"
Q&A: 16:50 - 17:00
Gabriel Rabinovich The Institute of Biology and Experimental Medicine/CONICET, Argentina
"The emerging role of glyco-checkpoints in cancer: the 'sweet' side of immunotherapy"
Q&A: 17:20 - 17:30
Welcome Reception
Drinks reception with buffet.
POSTER DISCUSSION SESSION 1
Listed times are in Central European Summer Time (CEST)
Poster viewing
Posters may be freely viewed. Tea/coffee/biscuits will be served..
Session 3
Chair: Lillian Siu
INDUSTRY SPOTLIGHT - Agilent Technologies
Miriam Contreras Mostazo Agilent
"How to assess T cell metabolic profile and further develop effective T cell therapies using Seahorse Analyzer"
Ignacio Melero Clínica Universidad de Navarra, Spain
"Tumor IL-8, NETs and the wrong type of tumor inflammation"
Q&A: 09:20 - 09:30
Jörg Wischhusen University Hospital Würzburg, Germany
Proffered Paper 2: "Tumor-derived GDF-15 prevents therapy success of checkpoint inhibitors by blocking T-lymphocyte recruitment"
Q&A: 09:40 - 09:45
Keren Yizhak Technion - Israel Institute of Technology, Israel
"Estimating tumor mutational burden from 'tumor-only' RNA-sequencing data"”
Q&A: 10:05 - 10:15
Mustafa Diken Germany
“The evolution of mRNA-vaccines against cancer”
Q&A: 10:35 - 10:45
COFFEE BREAK & EXHIBITION
THE EMBO KEYNOTE LECTURE
Yardena Samuels Weizmann Institute of Science, Israel
"Revisiting the Neoantigen Approach for Cancer Immunotherapy"
Q&A: 11:35 - 11:45
Macarena Román VHIO, Spain
Proffered Paper 3 : "p95HER2 CAR Ts secreting HER2 BITEs are a safe and effective immunotherapeutic strategy against HER2-positive tumors."
Q&A: 11:55 - 12:00
Poster Spotlights
3 top abstracts presented as 3-minute flash talks
INDUSTRY SYMPOSIUM - Bio-Rad Laboratories
Andrés Ramírez, PhD Flow Cytometry Regional Specialist, Bio-Rad
“Overcoming Bottlenecks in Research & Discovery with High-Throughput Flow Cytometry"
LUNCH & EXHIBITION
POSTER DISCUSSION SESSION 2
Session 4
Chair: Yardena Samuels
Industry Spotlight - LynxCare
Dr. Annelies Verbiest, PhD Department of Oncology, Antwerp University Hospital, Belgium
“Defense through Insights: Using AI to Unlock Real-World Evidence in Immunotherapy”
KEYNOTE LECTURE
Tyler Jacks MIT - Massachusetts Institute of Technology, USA
"Genetic engineering meets tumor immunology: Lessons from mouse models of cancer."
Q&A: 15:35 - 15:50
Lillian Siu University of Toronto, Canada
"Circulating DNA Applications in the Immuno-Oncology Era"
Q&A: 16:10 - 16:20
Marni Nishimoto Johns Hopkins, USA
Proffered Paper 4: "Transcriptional Programs of Tumor Specific CD4+ T Cells in NSCLC"
Q&A: 16:30 - 16:35
Giuseppina Arbore Ospedale San Raffaele, Italy
Proffered Paper 5: "Immune determinants of response to neoadjuvant chemotherapy in esophageal adenocarcinoma."
Q&A: 16:45 - 16:50
COFFEE BREAK & EXHIBITION
Chair: Joan Seoane
Pablo Umaña Roche, Switzerland
"Enhancing endogeneous and synthetic immunity with engineered antibody-fusion proteins for cancer immunotherapy"
Q&A: 17:40 - 17:50
Sergio Quezada Cancer Research UK, UK
"Regulatory T cells as Determinants of Adaptive and Innate Immune Function in Brain Tumours"
Q&A: 18:10 - 18:20
Meet the Scientific Programme Committee
Joan Seoane, Lillian Siu, Alena Gros, Ignacio Melero & Yardena Samuels
Our esteemed Scientific Programme Committee will come together to each provide insight into their personal and professional experiences of their routes into scientific leadership.
Conference Dinner
The dinner is being held at the 5* rated Hotel Casa Fuster, located just a short walk away from La Pedrera. Optional ticketed event. The dinner will end at 22:00 CEST.
Listed times are in Central European Summer Time (CEST)
Poster viewing
Posters may be freely viewed. Tea/coffee/biscuits will be served.
Session 5
Chair: Alena Gros
Andrea Ablasser EPFL, Switzerland
"Sensing DNA as a danger signal through the cGAS-STING pathway"
Q&A: 09:20 - 09:30
Marisol Soengas CNIO (Spanish National Cancer Research Centre), Spain
“Dissecting and targeting immune suppressive signals in the melanoma microenvironment”
Q&A: 09:50 - 10:00
Eudald Felip Institut Catala Oncologia, Spain
Proffered Paper 6: "Enhanced tumor immunity determines CDK4/6 inhibitor efficacy in advanced breast cancer (BC)."
Q&A: 10:10 - 10:15
COFFEE BREAK & EXHIBITION
Susan Galbraith (Pre-recorded Presentation) Astrazeneca, UK
‘Exploring the next wave of immuno-oncology therapies’
CLOSING KEYNOTE LECTURE
Josep Tabernero Vall d'Hebron Institute of Oncology (VHIO), Spain
Q&A: 11:45 - 12:00
SUMMARY & AWARDS
Depart
Key dates
Travel Grant application deadline:
13 February 2023
Abstract submission deadline:
13 February 2023
Registration deadline:
13 March 2023
